Company / Gross Margin
Celularity Inc Gross Margin History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
29.7%
FY2023
5-year range
-9.4% / 54.8%
FY2021-FY2023
Trend
+415.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin changed +416% YoY in FY2023, a notable deviation from the 2-year average annual change of +149%.
Based on SEC 10-K filings.
29.7% in FY2023.
Declined from 54.8% to 29.7% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, gross margin increased 415.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | 29.7% | +415.5% |
| FY2022 | -9.4% | -117.2% |
| FY2021 | 54.8% | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026